<DOC>
	<DOC>NCT02175693</DOC>
	<brief_summary>Investigation of the clinical condition and safety in patients with cervical dystonia</brief_summary>
	<brief_title>Post-marketing Surveillance of Administration of Botulinum Toxin Type B(NerBloc)-Investigation of the Clinical Condition and Safety in Patients With Cervical Dystonia</brief_title>
	<detailed_description />
	<mesh_term>Dystonia</mesh_term>
	<mesh_term>Dystonic Disorders</mesh_term>
	<mesh_term>Torticollis</mesh_term>
	<criteria>Inclusion criteria: Patients with cervical dystonia Exclusion criteria: The patients who participated in this surveillance in the past</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
	<keyword>Torticollis</keyword>
	<keyword>rimabotulinumtoxinB</keyword>
</DOC>